Hello,

"Supplements, although they have the ability to ensure their intake through the acidic environment of the stomach, contain high concentrations of monocultures, resulting in an imbalance in the diversity of the gut biome."
I am interested in whether some manufacturers take this into account and strive for lower concentrations and greater diversity? Or is this a problem with all probiotics in capsules in general? And at the same time, based on this logic, should one opt for probiotics in capsules only after antibiotic treatment and in case of digestive issues and not just casually? Additionally, I often encounter the use of probiotics for eczema; however, from what you're writing, I'm not sure if that's a good idea if eczema is mainly a question of microbiome disruption?

The development of supplements is continuously progressing, and probiotic manufacturers are certainly keeping pace. Nowadays, it is standard to target a broader spectrum of strains/genera/species, but even that is not "perfect," because:

1. From the perspective of diversity, values of 5-10 represented strains with which manufacturers work today solve nothing,
2. This trend does not correspond to the individual metabolic needs of a person.

However, if we were to work with an averaged individual from Western society, whose gut microbiota diversity is not entirely exemplary, it still makes sense to use probiotics in supplementation, as it will always benefit a healthy individual. In trying to support the resolution of certain health issues, you risk using a type of microorganism that may not meet the needs of the situation and could worsen the condition.

Companies are gradually emerging that offer personalized probiotics alongside gut microbiota analysis—here I am convinced that this is the direction of the future, and it makes sense to continuously monitor this area.

Themes:  Gut microbiome   Microbiota